News | October 29, 2007

NIH Awards Penn $2.1M for Cardiovascular Disease Management Study

October 30, 2007 – The National Institutes of Health (NIH) has awarded cardiac researchers at the University of Pennsylvania a $2.1 million grant to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
Penn is one of eight centers throughout the United States and Canada to be a named a Clinical Coordinating Center in the National Heart Lung and Blood Institute (NHLBI)-funded Clinical Research Network. This network will fund the creation of research and clinical trials that will answer questions in cardiothoracic surgery that have eluded researchers thus far.

The eight institutions that comprise the Cardiothoracic Surgical Network will collaborate over a five-year period to improve current technologies and create new ones to treat cardiovascular disease. “The establishment of this network will result in great benefit for patients. It also encourages leaders in cardiovascular surgery to share ideas, information, data and results,” said Michael Acker, M.D., chief of Cardiovascular Surgery at the Hospital of the University of Pennsylvania, and principal investigator for the grant.

“By enhancing the ability of research teams to evaluate new techniques, technologies and devices, the network promises to improve the scientific basis of care in cardiovascular disease,” said Elizabeth G. Nabel, M.D., director of the National Heart, Lung and Blood Institute of the National Institutes of Health.

The Penn researchers will propose protocols and participate in protocol development; screen and recruit cardiac surgery for up to five randomized clinical studies in cardiac surgery; develop strategies to encourage referrals from other specialty areas; draft publications and distribute research findings; and collaborate with other centers.

The seven other heart centers participating in this landmark NIH study are: the Cleveland Clinic, Columbia University, Duke Medical Center, Emory University, Montefiore-Einstein Heart Center, University of Virginia and the Montreal Heart Institute.

For more information: www.med.upenn.edu


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now